Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | Bone Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352187220300863 |
_version_ | 1828768993938243584 |
---|---|
author | Jacques P. Brown Arkadi Chines Roland Chapurlat Joseph Foldes Xavier Nogues Roberto Civitelli Tobias De Villiers Fabio Massari Cristiano Zerbini Wenjing Yang Chris Recknor Cesar Libanati |
author_facet | Jacques P. Brown Arkadi Chines Roland Chapurlat Joseph Foldes Xavier Nogues Roberto Civitelli Tobias De Villiers Fabio Massari Cristiano Zerbini Wenjing Yang Chris Recknor Cesar Libanati |
author_sort | Jacques P. Brown |
collection | DOAJ |
first_indexed | 2024-12-11T13:39:46Z |
format | Article |
id | doaj.art-add936b43c104d41b4f663e528e03a5d |
institution | Directory Open Access Journal |
issn | 2352-1872 |
language | English |
last_indexed | 2024-12-11T13:39:46Z |
publishDate | 2020-10-01 |
publisher | Elsevier |
record_format | Article |
series | Bone Reports |
spelling | doaj.art-add936b43c104d41b4f663e528e03a5d2022-12-22T01:04:49ZengElsevierBone Reports2352-18722020-10-0113100326Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trialJacques P. Brown0Arkadi Chines1Roland Chapurlat2Joseph Foldes3Xavier Nogues4Roberto Civitelli5Tobias De Villiers6Fabio Massari7Cristiano Zerbini8Wenjing Yang9Chris Recknor10Cesar Libanati11Laval University, Quebec City, CanadaAmgen Inc., Thousand Oaks, United StatesINSERM UMR 1033, University of Lyon, Lyon, FranceHadassah Hebrew University Medical Center, Jerusalem, IsraelIMIM Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, SpainWashington University School of Medicine, St. Louis, United StatesStellenbosch University, Stellenbosch, South AfricaInstituto de Investigaciones Metabólicas, Buenos Aires, ArgentinaCentro Paulista de Investigação Clinica, São Paulo, BrazilAmgen Inc., Thousand Oaks, United StatesUnited Osteoporosis Centers, Gainesville, United StatesUCB Pharma, Brussels, Belgium; Corresponding author.http://www.sciencedirect.com/science/article/pii/S2352187220300863 |
spellingShingle | Jacques P. Brown Arkadi Chines Roland Chapurlat Joseph Foldes Xavier Nogues Roberto Civitelli Tobias De Villiers Fabio Massari Cristiano Zerbini Wenjing Yang Chris Recknor Cesar Libanati Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial Bone Reports |
title | Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial |
title_full | Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial |
title_fullStr | Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial |
title_full_unstemmed | Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial |
title_short | Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial |
title_sort | romosozumab improves lumbar spine bmd and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the arch trial |
url | http://www.sciencedirect.com/science/article/pii/S2352187220300863 |
work_keys_str_mv | AT jacquespbrown romosozumabimproveslumbarspinebmdandbonestrengthgreaterthanalendronateasassessedbyquantitativecomputedtomographyandfiniteelementanalysisinthearchtrial AT arkadichines romosozumabimproveslumbarspinebmdandbonestrengthgreaterthanalendronateasassessedbyquantitativecomputedtomographyandfiniteelementanalysisinthearchtrial AT rolandchapurlat romosozumabimproveslumbarspinebmdandbonestrengthgreaterthanalendronateasassessedbyquantitativecomputedtomographyandfiniteelementanalysisinthearchtrial AT josephfoldes romosozumabimproveslumbarspinebmdandbonestrengthgreaterthanalendronateasassessedbyquantitativecomputedtomographyandfiniteelementanalysisinthearchtrial AT xaviernogues romosozumabimproveslumbarspinebmdandbonestrengthgreaterthanalendronateasassessedbyquantitativecomputedtomographyandfiniteelementanalysisinthearchtrial AT robertocivitelli romosozumabimproveslumbarspinebmdandbonestrengthgreaterthanalendronateasassessedbyquantitativecomputedtomographyandfiniteelementanalysisinthearchtrial AT tobiasdevilliers romosozumabimproveslumbarspinebmdandbonestrengthgreaterthanalendronateasassessedbyquantitativecomputedtomographyandfiniteelementanalysisinthearchtrial AT fabiomassari romosozumabimproveslumbarspinebmdandbonestrengthgreaterthanalendronateasassessedbyquantitativecomputedtomographyandfiniteelementanalysisinthearchtrial AT cristianozerbini romosozumabimproveslumbarspinebmdandbonestrengthgreaterthanalendronateasassessedbyquantitativecomputedtomographyandfiniteelementanalysisinthearchtrial AT wenjingyang romosozumabimproveslumbarspinebmdandbonestrengthgreaterthanalendronateasassessedbyquantitativecomputedtomographyandfiniteelementanalysisinthearchtrial AT chrisrecknor romosozumabimproveslumbarspinebmdandbonestrengthgreaterthanalendronateasassessedbyquantitativecomputedtomographyandfiniteelementanalysisinthearchtrial AT cesarlibanati romosozumabimproveslumbarspinebmdandbonestrengthgreaterthanalendronateasassessedbyquantitativecomputedtomographyandfiniteelementanalysisinthearchtrial |